Previously, some surgeons have delayed surgery for hip fracture patients on Aspirin and/or clopidogrel. This systematic review suggests at worse that there is no advantage to this practice or that in fact, the advantage is for patients where surgery is not delayed. The benefit of implementing this recommendation is preventing an unnecessary (unhelpful) delay in performing hip fracture surgery.
As with all surgical procedures, there are potential risks and complications, including, but not limited to, the possibility of bleeding. There is no data suggesting patient outcome harms will occur with the implementation of this recommendation.